Many individuals cite prescription opioids as their gateway to illicit opioid use. However, while prescription opioids are involved in more than one-third of all opioid overdose deaths in the U.S., examining any correlation between prescription opioid overdose deaths and pharmaceutical industry marketing has been limited — until now. New research from NYU School of Medicine
Several states are likely dramatically underestimating the effect of opioid-related deaths because of incomplete death certificate reporting, with Pennsylvania leading the pack, according to a new analysis by the University of Pittsburgh Graduate School of Public Health. The study, published today in Public Health Reports, the journal of the Office of the U.S. Surgeon General,
Most participants in clinical trials believe the benefits of broadly sharing person-level data outweigh the risks, according to a new study by Stanford University researchers. And despite low levels of trust in pharmaceutical companies, most of those who take part in clinical trials are willing to share their data with drug firms, the researchers found.
A new RAND Corporation paper finds that artificial intelligence has the potential to upend the foundations of nuclear deterrence by the year 2040. While AI-controlled doomsday machines are considered unlikely, the hazards of artificial intelligence for nuclear security lie instead in its potential to encourage humans to take potentially apocalyptic risks, according to the paper.